Efficacy and Safety of Lianhua Qingwen for Patients with COVID-19: A Systematic Review and Meta-Analysis
ConclusionsLHQW was more suitable for treating COVID-19 patients with obvious expectoration, shortness of breath and muscle soreness. LHQW had advantages in treating COVID-19 with no obvious exacerbation. (PROSPERO No. CRD42021235937)
Source: Chinese Journal of Integrative Medicine - Category: Internal Medicine Source Type: research
More News: Chemistry | China Health | Cough | COVID-19 | CT Scan | Databases & Libraries | Gastroenterology | Internal Medicine | Outbreaks | Respiratory Medicine | Study